The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy

Morten Orebo Holmstrom; Hans Carl Hasselbalch; Mads Hald Andersen

doi:10.1080/2162402x.2017.1358334

The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy

Morten Orebo Holmstrom, Hans Carl Hasselbalch, Mads Hald Andersen

Department of Clinical Medicine

4 Citations (Scopus)

Original language	English
Article number	e1358334
Journal	OncoImmunology
Volume	6
Issue number	11
Number of pages	3
ISSN	2162-4011
DOIs	https://doi.org/10.1080/2162402x.2017.1358334
Publication status	Published - 2 Nov 2017

Keywords

CD4 T-cells
calreticulin
Hematological cancer
JAK2
neoantigens

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/2162402x.2017.1358334

2162402X.2017.1358334?needAccess=trueFinal published version, 872 KB

Cite this

@article{54a7ba22c38247c4b2681ad7c4d6ed8d,

title = "The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy",

keywords = "CD4 T-cells, calreticulin, Hematological cancer, JAK2, neoantigens",

author = "Holmstrom, {Morten Orebo} and Hasselbalch, {Hans Carl} and Andersen, {Mads Hald}",

year = "2017",

month = nov,

day = "2",

doi = "10.1080/2162402x.2017.1358334",

language = "English",

volume = "6",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Taylor & Francis",

number = "11",

}

TY - JOUR

T1 - The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy

AU - Holmstrom, Morten Orebo

AU - Hasselbalch, Hans Carl

AU - Andersen, Mads Hald

PY - 2017/11/2

Y1 - 2017/11/2

KW - CD4 T-cells

KW - calreticulin

KW - Hematological cancer

KW - JAK2

KW - neoantigens

U2 - 10.1080/2162402x.2017.1358334

DO - 10.1080/2162402x.2017.1358334

M3 - Journal article

C2 - 29147619

SN - 2162-4011

VL - 6

JO - OncoImmunology

JF - OncoImmunology

IS - 11

M1 - e1358334

ER -

The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this